Amyris Inc (NASDAQ:AMRS)’s Biossance Delivers Record First-Quarter Sales

Amyris Inc (NASDAQ:AMRS)

Amyris Inc (NASDAQ:AMRS), an industrial bioscience company, has reported the first-quarter product sales for the Biossance brand. The product has shown impressive sales growth rates and is expected to maintain the trend in 2017.

Biossance Squalane + Peptide Eye Gel is the number one selling eye medicinal product at SEPHORA.com. The company’s products have also been highly reviewed in several leading publications.

While commenting on the latest developments, the company’s President and CEO John Melo said they are excited by the contribution being made by Biossance to Amyris’ personal care line as well as the high rate of growth the company is recording in the nutrition business.

In yet another segment, Amyris recently announced the unveiling of the new tackifying resins produced by Cray Valley using Amyris’ biologically derived farnesene selling under the brand name Biofene®. Amyris’s farnesene has a disruptive nature which allowed Cray Valley to develop new tackifying resins basing on monomers derived from sustainable biomaterials. Consequently, the farnesene-based resins are not affected by supply instabilities and costs of monomers which are based on petroleum. They are also not subject to natural variabilities which greatly impair the quality of limonene and pinene monomers

The Wingtack group of tackifying resins from Cray Valley are made using piperylene. Cray Valley has been leveraging new technology to utilize farnesene and replace 30% of piperylene as well as incorporating Wingtack® EXTRA F30 into its tackifiers product line without compromising on performance – especially in hot melt usage.

According to data from research company MarketsandMarkets.com, the global market for tackifier is expected to hit $3.56 billion by 2020. This is a big opportunity for renewable farnesene-based tackifiers and Amyris hopes to exploit this market as its products achieve market scale.

Amyris is an integrated company engaged in the production of renewable products to achieve sustainable growth. The company uses innovative solutions to transform plant sugars into molecules of hydrocarbon in addition to producing consumer products and specialty ingredients. Amyris is working to unveil its No Compromise® products in several markets including performance and specialty chemicals, fragrances, flavors, pharmaceuticals, cosmetics ingredients and nutraceuticals. Total Cray Valley, based in Paris, is a subsidiary of Total’s Polymers division and part of the Refining & Chemicals branch.

Ticker AMRS
Market Cap $191.67M
EPS (ttm) -$0.36
Shares Outstanding 273.82M
Shares Float 206.82M
Insider Ownership 0.80%
Float Short 4.99%
Short Ratio 3.8
Performance (Quarter) -2.78%
Performance (Year) -33.33%
Performance (YTD) -4.11%
Beta 0.43
Average Volume 2.72M
Price $0.7
Volume 9,599,300
Target Price $2.77

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

About the author: Monica Gray has an undergraduate degree in Accounting and an MBA – earned with Honors. She has six years of experience in the financial markets and has been a securities analyst for the past two years.

Author: Monica Gray

Monica has an undergraduate degree in Accounting and an MBA she earned - with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.

Leave a Reply

Your email address will not be published. Required fields are marked *